University of California Los Angeles-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain

    Clinical Therapeutics, Vol. 39, Núm. 4, pp. 771-786.e3